Private company

Invitae

Logo: invitae.com⁴

American medical laboratories services company based in San Francisco. Summary from the record

Last updated Oct 19, 2026.

Overview

2010Founded¹

IndustryServices-Medical Laboratories¹
HeadquartersSan Francisco¹
Websitewww.invitae.com/en
Legal formDelaware corporation¹
Incorporated inDE⁵
Business address1400 16Th Street, San Francisco, Ca 94103⁵
Filer categoryLarge accelerated filer⁵
LEI549300MYI59DZW1WIX92³
StatusActive³
LEI statusLapsed (not renewed)³
Registered addressC/O The Corporation Trust Company, 19801 Wilmington, United States³
Registered withDivision of Corporations, Department of State, 4741049³

See how the biggest companies compare on our leaderboards

Invitae image from its website — Image: invitae.com⁴

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-604.0%Operating margin⁶

-600.4%Net margin⁷

12.1%Revenue growth, 2022⁶

-3044.1%Return on equity⁶

-$546.3MFree cash flow⁷

Where the money goes

Where each dollar of revenue went, fiscal 2022

Cost of revenueResearch and development

Cost of revenue45¢$417.3M
Research and development44¢$402.1M
Interest6¢$56.7M
Income tax5¢$44.9M

Out of $516.3M in revenue.⁶⁷ The company lost money this year.

Financial statements

Revenue⁸⁹¹⁰¹¹⁶$516.3M in 2022+1961% since 2016

Operating income⁸⁹¹⁰¹¹⁶-$3.1B in 2022+3013% since 2016

Net income⁸⁹¹⁰¹¹⁷-$3.1B in 2022+2992% since 2016

Fiscal year	2016	2017	2018	2019	2020	2021	2022
Revenue	$25.0M⁸	$68.2M⁹	$147.7M¹⁰	$216.8M¹¹	$279.6M⁶	$460.4M⁶	$516.3M⁶
Cost of revenue	$27.9M⁸	$50.1M⁹	$80.1M¹⁰	$118.1M¹¹	$198.3M⁶	$348.7M⁶	$417.3M⁶
Research and development	$44.6M⁸	$46.5M⁹	$63.5M¹⁰	$141.5M¹¹	$240.6M⁶	$416.1M⁶	$402.1M⁶
Operating expenses						$852.1M⁶	$3.6B⁶
Operating income	-$100.2M⁸	-$121.3M⁹	-$122.6M¹⁰	-$244.1M¹¹	-$652.2M⁶	-$391.6M⁶	-$3.1B⁶
Interest	$421.0K⁸	$3.7M⁹	$7.0M¹⁰	$12.4M¹¹	$29.8M⁶	$49.9M⁶	$56.7M⁶
Income before tax						-$415.9M⁶	-$3.2B⁶
Income tax	$0⁸	-$1.9M⁹	-$2.8M¹⁰	-$18.4M¹¹	-$112.1M⁶	-$36.9M⁶	-$44.9M⁶
Net income	-$100.3M⁸	-$123.4M⁹	-$129.4M¹⁰	-$242.0M¹¹	-$602.2M⁷	-$379.0M⁷	-$3.1B⁷
Earnings per share				-$2.66¹¹	-$4.47⁶	-$1.80⁶	-$13.18⁶
Earnings per share (diluted)				-$2.66¹¹	-$4.47⁶	-$1.80⁶	-$13.18⁶
Shares (weighted, basic)						210.9M shares⁶	235.7M shares⁶
Shares (weighted, diluted)						210.9M shares⁶	235.7M shares⁶

Total assets¹⁴⁸⁹¹⁰¹¹⁶$2.0B in 2022+1396% since 2016

Total liabilities¹⁴⁸⁹¹⁰¹¹⁶$1.9B in 2022+5766% since 2016

Shareholders’ equity⁸⁹¹⁰¹¹⁶$101.8M in 2022+3% since 2016

Cash¹⁴⁸⁹¹⁰¹¹⁶$257.5M in 2022+285% since 2016

Long-term debt¹⁴⁸⁹$0 in 2019

Fiscal year	2016	2017	2018	2019	2020	2021	2022
Cash	$66.8M¹⁴	$12.1M⁸	$112.2M⁹	$151.4M¹⁰	$124.8M¹¹	$923.2M⁶	$257.5M⁶
Receivables						$66.2M⁶	$96.1M⁶
Inventory						$33.5M⁶	$30.4M⁶
Current assets	$101.8M¹⁴	$86.7M⁸	$165.4M⁹	$442.4M¹⁰	$453.9M¹¹	$1.2B⁶	$693.1M⁶
Property, plant and equipment						$114.7M⁶	$108.7M⁶
Goodwill						$2.3B⁶	$0⁶
Intangible assets						$1.2B⁶	$1.0B⁶
Total assets	$130.7M¹⁴	$211.1M⁸	$283.0M⁹	$781.6M¹⁰	$3.4B¹¹	$4.9B⁶	$2.0B⁶
Accounts payable						$21.1M⁶	$14.0M⁶
Current liabilities	$14.8M¹⁴	$33.4M⁸	$36.3M⁹	$81.9M¹⁰	$121.7M¹¹	$144.1M⁶	$108.1M⁶
Long-term debt	$8.7M¹⁴	$39.1M⁸	$74.5M⁹	$0⁹
Total liabilities	$31.6M¹⁴	$89.3M⁸	$121.1M⁹	$402.0M¹⁰	$1.5B¹¹	$1.9B⁶	$1.9B⁶
Retained earnings						-$1.7B⁶	-$4.8B⁶
Shareholders’ equity	$99.1M⁸	$121.8M⁹	$161.8M¹⁰	$379.6M¹¹	$2.0B⁶	$3.0B⁶	$101.8M⁶
Shares outstanding	41.1M shares¹⁴	53.6M shares⁸	75.5M shares⁹	98.8M shares¹⁰	185.9M shares¹¹	228.1M shares⁶	245.6M shares⁶

Cash from operations⁸⁹¹⁰¹¹⁷-$493.0M in 2022+546% since 2016

Capital spending⁸⁹¹⁰¹¹⁶$53.3M in 2022+359% since 2016

Free cash flow⁸⁹¹⁰¹¹⁷-$546.3M in 2022+521% since 2016

Fiscal year	2016	2017	2018	2019	2020	2021	2022
Cash from operations	-$76.3M⁸	-$98.0M⁹	-$92.2M¹⁰	-$145.1M¹¹	-$298.5M⁷	-$559.8M⁷	-$493.0M⁷
Depreciation and amortization						$80.5M⁶	$142.1M⁶
Stock-based compensation						$180.1M⁶	$199.3M⁶
Capital spending	$11.6M⁸	$6.7M⁹	$6.0M¹⁰	$20.0M¹¹	$22.9M⁶	$54.7M⁶	$53.3M⁶
Free cash flow	-$87.9M	-$104.7M	-$98.2M	-$165.1M	-$321.4M	-$614.5M	-$546.3M
Cash from investing						-$204.1M⁶	-$174.8M⁶
Cash from financing						$1.6B⁶	$1.8M⁶

Compare Invitae with another company

Leadership

Who has led Invitae, and when. Pick a name to see everywhere that person has worked.

Chief executive

Chair

Randal W. Scott2015–2019

President

Sean E. George2015–2022

Chief financial officer

Chief operating officer

201520202025

Chief executive officerKenneth D. Knight Jul 19, 2022 to May 18, 2023¹⁵
Chief executive officerSean E. George Feb 7, 2017 to May 19, 2022¹⁶
Chief executive officerRandal W. Scott Feb 11, 2015 to Nov 22, 2016¹⁷
ChairRandal W. Scott Feb 11, 2015 to Aug 27, 2019¹⁷
PresidentSean E. George Feb 11, 2015 to May 19, 2022¹⁸
Chief financial officerAna J. Schrank Oct 2, 2023 to Oct 2, 2023¹⁹
Chief financial officerYafei Wen Jun 23, 2021 to May 24, 2023²⁰
Chief financial officerShelly D. Guyer Jun 13, 2017 to Jun 16, 2021²¹
Chief financial officerE. Lee Bendekgey Feb 11, 2015 to Feb 15, 2017²²
Chief operating officerDavid Sholehvar Nov 14, 2023 to Nov 14, 2023²³
Chief operating officerKenneth D. Knight Jul 8, 2020 to May 19, 2022²⁴
Chief operating officerE. Lee Bendekgey May 16, 2018 to Jul 15, 2020²⁵
Chief operating officerSean E. George Feb 11, 2015 to Apr 4, 2016¹⁸

Board members and other officers (19)

OfficerJeff Parsons Jul 11, 2023 to Jul 11, 2023²⁶
Chief Commercial OfficerRobert M. Guigley Sep 14, 2023 to Sep 25, 2023²⁷
OfficerThomas Brida May 19, 2022 to Dec 21, 2023²⁸
Chief Accounting OfficerRobert F. Werner May 27, 2020 to May 18, 2023²⁹
VP Fin. & Principal Acct. Off.Patty Dumond Mar 2, 2016 to Mar 1, 2019³⁰
Chief Commercial OfficerKatherine Stueland Nov 14, 2016 to Jun 16, 2021³¹
Sr. Vice President, MarketingLisa Alderson Feb 11, 2015 to Mar 2, 2016³²
Chief Medical OfficerRobert L. Nussbaum Aug 3, 2015 to Dec 21, 2023³³
Board memberWilliam H. Osborne Jan 30, 2023 to May 1, 2023³⁴
Board memberKenneth D. Knight Jul 19, 2022 to May 18, 2023¹⁵
Board memberRandal W. Scott Jul 19, 2022 to May 1, 2023³⁵
Board memberJason W. Myers Feb 22, 2021 to Feb 22, 2021³⁶
Board memberKimber D. Lockhart Sep 11, 2020 to May 1, 2023³⁷
Board memberChitra Nayak Sep 11, 2018 to May 1, 2023³⁸
Board memberEric Aguiar Feb 11, 2015 to May 1, 2023³⁹
Board memberGeoffrey Crouse Feb 11, 2015 to May 1, 2023⁴⁰
Board memberSean E. George Feb 11, 2015 to Dec 20, 2022¹⁸
Board memberChristine Marie Gorjanc Nov 6, 2015 to May 1, 2023⁴¹
General counselThomas Brida Jan 23, 2017 to Apr 12, 2022⁴²

Former names

Locus Development IncSep 15, 2010 to Mar 29, 2011⁵

Timeline

2024Dissolved Dissolved¹
Jul 19, 2022New chief executive Kenneth D. Knight becomes CEO¹⁵
Feb 7, 2017New chief executive Sean E. George becomes CEO¹⁶
Feb 11, 2015New chief executive Randal W. Scott becomes CEO¹⁷
2010Founded Founded¹

Filings

181 filings to the SEC since October 2021: 2 annual reports, 7 quarterly reports, 52 major events, 74 insider forms, 18 large holders, 28 other. The latest 20:

Jan 10, 2025SCHEDULE 13G/A EDGAR
Aug 8, 20248-K EDGAR
Jul 31, 20248-K EDGAR
Jul 1, 20248-K EDGAR
Jun 4, 20248-K EDGAR
May 2, 20248-K EDGAR
Apr 4, 20248-K EDGAR
Mar 6, 20248-K EDGAR
Feb 14, 20248-K EDGAR
Feb 13, 2024SC 13G/A EDGAR
Feb 13, 2024SC 13G/A SCHEDULE 13G/A EDGAR
Feb 6, 20248-K EDGAR
Feb 5, 2024SC 13G/A AMENDMENT NO. 4 EDGAR
Jan 29, 2024SC 13G/A EDGAR
Jan 24, 20248-K/A EDGAR
Jan 22, 20248-K EDGAR
Jan 18, 20248-K EDGAR
Jan 12, 20248-K/A EDGAR
Dec 21, 20234 EDGAR
Dec 21, 20234 EDGAR

The 181 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

33 open-market trades by officers, directors and large owners since October 2021: 0 buys and 33 sales. Grants, option exercises and gifts are left out.

Date	Who	Trade	Shares	Price	Value	Filing
Jun 13, 2023	Nussbaum Robert LChief Medical Officer	Sale	7,086	$1.38	$9.8K	Form 4
Jun 13, 2023	Brida ThomasSee Remarks	Sale	7,079	$1.38	$9.8K	Form 4
May 16, 2023	Wen YafeiChief Financial Officer	Sale	43,452	$1.20	$52.1K	Form 4
May 16, 2023	Knight Kenneth D.Chief Executive Officer	Sale	45,432	$1.20	$54.5K	Form 4
May 16, 2023	Nussbaum Robert LChief Medical Officer	Sale	26,476	$1.20	$31.8K	Form 4
May 16, 2023	Wen YafeiChief Financial Officer	Sale	43,452	$1.99	$86.5K	Form 4
May 16, 2023	WERNER ROBERT F.Chief Accounting Officer	Sale	21,559	$1.20	$25.9K	Form 4
May 16, 2023	Brida ThomasSee Remarks	Sale	26,476	$1.20	$31.8K	Form 4
Mar 13, 2023	Brida ThomasSee Remarks	Sale	2,625	$1.41	$3.7K	Form 4
Mar 13, 2023	Nussbaum Robert LChief Medical Officer	Sale	2,625	$1.41	$3.7K	Form 4
Mar 13, 2023	Wen YafeiChief Financial Officer	Sale	2,625	$1.41	$3.7K	Form 4
Mar 13, 2023	Knight Kenneth D.Chief Executive Officer	Sale	1,853	$1.41	$2.6K	Form 4
Dec 19, 2022	George Sean EDirector	Sale	11,163	$2.08	$23.2K	Form 4
Dec 16, 2022	George Sean EDirector	Sale	44,816	$2.04	$91.4K	Form 4
Aug 25, 2022	WERNER ROBERT F.Chief Accounting Officer	Sale	1,350	$3.45	$4.7K	Form 4
Aug 16, 2022	Brida ThomasSee Remarks	Sale	7,048	$4.55	$32.1K	Form 4
Aug 16, 2022	Nussbaum Robert LChief Medical Officer	Sale	7,048	$4.55	$32.1K	Form 4
Aug 16, 2022	George Sean EDirector	Sale	22,085	$4.55	$100.5K	Form 4
Aug 16, 2022	WERNER ROBERT F.Chief Accounting Officer	Sale	3,252	$4.55	$14.8K	Form 4
May 19, 2022	WERNER ROBERT F.Chief Accounting Officer	Sale	2,746	$3.40	$9.3K	Form 4

All 33 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

ARK Investment Management LLCSCHEDULE 13G/A, 5 filings Oct 12, 2021 to Jan 10, 2025⁴³
Amova Asset Management Americas, Inc.SC 13G/A, 3 filings Feb 14, 2022 to Feb 13, 2024⁴⁴
VANGUARD GROUP INCSC 13G/A, 3 filings Feb 10, 2022 to Feb 13, 2024⁴⁵
Sumitomo Mitsui Trust GroupSC 13G/A, 3 filings Feb 4, 2022 to Feb 5, 2024⁴⁶
James E. FlynnSC 13G, 1 filing Aug 30, 2023⁴⁷
Casdin Capital, LLCSC 13G/A, 2 filings Feb 14, 2022 to Feb 14, 2023⁴⁸
BAKER BROS. ADVISORS LPSC 13G/A, 1 filing Feb 14, 2022⁴⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataInvitae on Wikidata
2
SEC EDGARInvitae filings on SEC EDGAR
3
GLEIFInvitae LEI record (549300MYI59DZW1WIX92)
4
Company websiteInvitae logo
5
SEC EDGARInvitae filings on SEC EDGAR
6
SEC EDGARInvitae 10-K for fiscal 2022
7
SEC EDGARInvitae 10-K for fiscal 2022
8
SEC EDGARInvitae 10-K for fiscal 2016
9
SEC EDGARInvitae 10-K for fiscal 2017
10
SEC EDGARInvitae 10-K for fiscal 2018
11
SEC EDGARInvitae 10-K for fiscal 2019
12
SEC EDGARInvitae 10-Q for fiscal 2023
13
SEC EDGARInvitae 10-Q for fiscal 2023
14
SEC EDGARInvitae 10-K for fiscal 2016
15
SEC EDGARKenneth D. Knight, Chief executive officer
16
SEC EDGARSean E. George, Chief executive officer
17
SEC EDGARRandal W. Scott, Chief executive officer
18
SEC EDGARSean E. George, President
19
SEC EDGARAna J. Schrank, Chief financial officer
20
SEC EDGARYafei Wen, Chief financial officer
21
SEC EDGARShelly D. Guyer, Chief financial officer
22
SEC EDGARE. Lee Bendekgey, Chief financial officer
23
SEC EDGARDavid Sholehvar, Chief operating officer
24
SEC EDGARKenneth D. Knight, Chief operating officer
25
SEC EDGARE. Lee Bendekgey, Chief operating officer
26
SEC EDGARJeff Parsons, Officer
27
SEC EDGARRobert M. Guigley, Chief Commercial Officer
28
SEC EDGARThomas Brida, Officer
29
SEC EDGARRobert F. Werner, Chief Accounting Officer
30
SEC EDGARPatty Dumond, VP Fin. & Principal Acct. Off.
31
SEC EDGARKatherine Stueland, Chief Commercial Officer
32
SEC EDGARLisa Alderson, Sr. Vice President, Marketing
33
SEC EDGARRobert L. Nussbaum, Chief Medical Officer
34
SEC EDGARWilliam H. Osborne, Board member
35
SEC EDGARRandal W. Scott, Board member
36
SEC EDGARJason W. Myers, Board member
37
SEC EDGARKimber D. Lockhart, Board member
38
SEC EDGARChitra Nayak, Board member
39
SEC EDGAREric Aguiar, Board member
40
SEC EDGARGeoffrey Crouse, Board member
41
SEC EDGARChristine Marie Gorjanc, Board member
42
SEC EDGARThomas Brida, General counsel
43
SEC EDGARARK Investment Management LLC SCHEDULE 13G/A on Invitae
44
SEC EDGARAmova Asset Management Americas, Inc. SC 13G/A on Invitae
45
SEC EDGARVANGUARD GROUP INC SC 13G/A on Invitae
46
SEC EDGARSumitomo Mitsui Trust Group SC 13G/A on Invitae
47
SEC EDGARJames E. Flynn SC 13G on Invitae
48
SEC EDGARCasdin Capital, LLC SC 13G/A on Invitae
49
SEC EDGARBAKER BROS. ADVISORS LP SC 13G/A on Invitae